Harmony Biosciences director files initial Form 3

Harmony Biosciences Holdings, Inc. director Troy A. Ignelzi filed an initial Form 3, which is a required statement of beneficial ownership for insiders.

Accepted by SEC EDGAR 04/06/2026 - 04:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Harmony Biosciences Holdings, Inc. director Troy A. Ignelzi filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing lists him as a director of the company but shows no reported transactions or specific share holdings at this time.

Key Terms

Form 3, director, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

director financial

""is_director": 1"

ten percent owner financial

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Harmony Biosciences (HRMY) Form 3 by Troy A. Ignelzi show?

The Form 3 shows Troy A. Ignelzi as a director of Harmony Biosciences. It is an initial insider ownership report and, in this case, does not list any specific share holdings or transactions for him.

Does the HRMY Form 3 for Troy A. Ignelzi report any stock transactions?

No, the Form 3 for Troy A. Ignelzi reports no stock transactions. The transaction summary shows zero buys, zero sells, and no derivative exercises, meaning it is purely an initial ownership statement without trades.

Is Troy A. Ignelzi a 10% owner of Harmony Biosciences (HRMY)?

According to the Form 3, Troy A. Ignelzi is not a 10% owner of Harmony Biosciences. He is identified as a director, with the ten percent owner flag set to zero, indicating he is not reported as a large shareholder.

Does the HRMY Form 3 disclose any derivative securities for Troy A. Ignelzi?

No, the filing shows no derivative securities for Troy A. Ignelzi. The derivative summary is empty, and the transaction summary lists zero derivative transactions or exercises, so no options or similar instruments are disclosed here.

Why is a Form 3 important for Harmony Biosciences (HRMY) investors?

Form 3 is important because it identifies insiders like directors and officers when they become reporting persons. It establishes a baseline for future Form 4 and Form 5 filings, which will show any subsequent trades or changes in their holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ignelzi Troy A.

(Last) (First) (Middle)

C/O HARMONY BIOSCIENCES HOLDINGS, INC.

630 W. GERMANTOWN PIKE, SUITE 215

(Street)

PLYMOUTH MEETING PENNSYLVANIA 19462

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/02/2026

3. Issuer Name and Ticker or Trading Symbol
Harmony Biosciences Holdings, Inc. [ HRMY ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Christian Ulrich, Attorney-in-Fact	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)